June 29, 2022 — Adult survivors of cancer have a higher risk of heart failure and other cardiovascular diseases (CVD) later in life than adults without cancer, according to results of a large study led by Johns Hopkins Medicine researchers.

June 29, 2022 — While lower vertebrates can repair their adult hearts after a heart attack, mammals — including humans — cannot. The ability to regenerate dead muscle tissue in mammalian hearts disappears just a few days after birth because the heart muscle cells, called cardiomyocytes, exit the cell cycle. 

June 28, 2022 — – Atlas Healthcare Partners – which specializes in developing and managing ambulatory surgery centers (ASCs) – and MedAxiom – which is dedicated to cardiovascular organizational performance improvement – today announced the formation of a first-of-its-kind cardiovascular-focused ASC company. Together, Atlas and MedAxiom will transform cardiovascular care by expanding access to high quality, patient-centered heart care in ASCs.  

June 27, 2022 — Three articles and an accompanying editorial provide information on the effects of Long COVID in the Deutsches Ärzteblatt International’s volume 10, a themed issue on the subject. 

June 27, 2022 — Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the commercial launch of an expanded suite of left-heart access products to now include the AcQCross Qx system for use with the

June 27, 2022 — Results from one of the largest global studies of atrial fibrillation (AFib) procedures show that the simple approach is usually best when it comes to ablation, a procedure where physicians destroy or ablate

Diagnostic and Interventional Cardiology (DAIC) continues to evolve with this ever-changing market to help keep you, our valued audience, on the leading-edge of new trends, products and technology in the field of cardiology.

Dyad Medical’s IVOCT imaging app has 3D visualization capabilities.

Artificial intelligence’s (AI) applicability in cardiac imaging is rapidly growing and was a major topic of discussion at this year’s EuroPCR 2022 meeting.
Harding University in Searcy, Ark. will be the first institution in the nation to create a Master of Science in Cardiac Function and Interventional Technology (CFIT) Program.

Driven by an aging population and a growing incidence of heart disease, the cardiac device industry is seeing exponential growth in technology, innovation and revenue. With that growth has come an explosion of demand for those with the training and experience to support and service today's next-generation cardiac devices.

A rise in cardiovascular diseases has fueled technological advancements in thrombectomy devices

The global thrombectomy devices market is poised to experience substantial expansion, owing to the emergence of cardiovascular disorders due to the prevalence of lifestyle diseases like diabetes, unhealthy dietary habits, obe
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now